Topo - 1 inhibitor ADCs
Search documents
Whitehawk Therapeutics (NasdaqCM:AADI) 2025 Conference Transcript
2025-11-18 12:32
Whitehawk Therapeutics (NasdaqCM:AADI) 2025 Conference November 18, 2025 06:30 AM ET Company ParticipantsDave Lennon - President and CEOConference Call ParticipantsRoger Song - Senior Equity Research AnalystRoger SongExcellent. All right. Welcome, everyone, to Jefferies Healthcare London Conference 2025. My name is Roger Song, one of the senior analysts covering biotech in the U.S. It is my pleasure to introduce our next presenting company from Whitehawk and the CEO, Dave Lennon. Dave, welcome.Dave LennonTh ...